Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec

Urologia Internationalis

Volumn 97, Issue 1, 2016, Pages 49-53

  Zakaria, Ahmed S ^a   Santos, Fabiano ^b   Kassouf, Wassim ^a   Tanguay, Simon ^a   Aprikian, Armen ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

De novo; Non muscle invasive bladder cancer; Progressive; Quebec; Radical cystectomy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HAZARD RATIO; HEALTH INSURANCE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; QUEBEC; RANK SUM TEST; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; MORTALITY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AGED; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, SECOND PRIMARY; QUEBEC; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84957917049     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000444093     Document Type: Article

References (20)

1. Mossanen M, Gore JL: The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol 2014; 24: 487-491.
2. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, Canadian Cancer Society, 2014.
3. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-475; discussion 475-477.
4. Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, et al: Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy. Urol Int 2013; 91: 97-102.
5. de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S: Survival after cystectomy for invasive bladder cancer. Eur J Surg Oncol 2010; 36: 292-297.
6. Ferreira U, Matheus WE, Nardi Pedro R, Levi D'Ancona CA, Reis LO, Stopiglia RM, et al: Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate. Urol Int 2007; 79: 200-203.
7. May M, Braun KP, Richter W, Helke C, Vogler H, Hoschke B, Siegsmund M: [Radical cystectomy in the treatment of bladder cancer always in due time?]. Urologe A 2007; 46: 913-919.
8. Türkölmez K, Tokgöz H, Reşorlu B, Köse K, Bedük Y: Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urology 2007; 70: 477-481.
9. Lee CT, Dunn RL, Ingold C, Montie JE, Wood DP Jr: Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology 2007; 69: 1068-1072.
10. May M, Helke C, Nitzke T, Vogler H, Hoschke B: Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 2004; 72: 103-111.
11. Yiou R, Patard JJ, Benhard H, Abbou CC, Chopin D: Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 2002; 89: 374-378.
12. Hidas G, Pode D, Shapiro A, Katz R, Appelbaum L, Pizov G, et al: The natural history of secondary muscle-invasive bladder cancer. BMC Urol 2013; 13: 23.
13. Kotb AF, Kovac E, Kassouf W, Chin J, Fradet Y, Izawa J, et al: Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? World J Urol 2012; 30: 761-767.
14. Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F: De novo muscle invasive bladder cancer: is there a change in trend? J Urol 2001; 165: 47-50; discussion 50.
15. Schrier BP, Hollander MP, van Rhijn BW, Kiemeney LA, Witjes JA: Prognosis of muscleinvasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004; 45: 292-296.
16. Hornák M, Bárdos A: [Biologic characteristics of invasive bladder cancer: is there a difference between primary and progressive tumours?]. Rozhl Chir 2004; 83: 648-650.
17. Zakaria AS, Santos F, Dragomir A, Tanguay S, Kassouf W, Aprikian AG: Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: a population-based analysis during the years 2000-2009. Can Urol Assoc J 2014; 8: 259-267.
18. Santos F, Zakaria AS, Kassouf W, Tanguay S, Aprikian A: High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec. World J Urol 2015; 33: 1323-1330.
19. Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, et al: Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy -A prospective multicenter study. Urol Int 2015, Epub ahead of print.
20. Berger I, Wehrberger C, Ponholzer A, Wolfgang M, Martini T, Breinl E, et al: Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older. Urol Int 2015; 94: 394-400.